Matteo Massa

New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment

Chiara Brullo, Roberta Ricciarelli, Jos Prickaerts et al. · European Journal of Medicinal Chemistry · 2016 · 38 citations

Medicinal Chemistry, Alzheimer's Disease, Structural Development +11

The AGROBOT project

Francesco Buemi, Matteo Massa, Giulio Sandini et al. · Advances in Space Research · 1996 · 19 citations

Engineering, Agrobot Project, Field Robotics +5

Synthesis, Biological Evaluation, and Molecular Modeling of New 3-(Cyclopentyloxy)-4-methoxybenzaldehyde <i>O</i>-(2-(2,6-Dimethylmorpholino)-2-oxoethyl) Oxime (GEBR-7b) Related Phosphodiesterase 4D (PDE4D) Inhibitors

Chiara Brullo, Matteo Massa, Massimo Rocca et al. · Journal of Medicinal Chemistry · 2014 · 19 citations · Full text

Drug Target, New Series, Chemical Biology +19

Synthesis, biological activities and pharmacokinetic properties of new fluorinated derivatives of selective PDE4D inhibitors

Chiara Brullo, Matteo Massa, Carla Villa et al. · Bioorganic & Medicinal Chemistry · 2015 · 18 citations · Full text

Derivative (Chemistry), Pharmaceutical Chemistry, Medicine +9

New Hybrid Pyrazole and Imidazopyrazole Antinflammatory Agents Able to Reduce ROS Production in Different Biological Targets

Chiara Brullo, Matteo Massa, Federica Rapetti et al. · Molecules · 2020 · 17 citations · Full text